Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tolperisone - Sanochemia Pharmazeutika

Next Previous
X
Search
Drug Profile

Tolperisone - Sanochemia Pharmazeutika

Alternative Names: Agileo; AV-650; Instant release (IR) tolperisone tablets - Sanochemia; SPH-3047; Sustained release tolperisone tablets - Sanochemia; Tolcare; Viveo

Latest Information Update: 28 Dec 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sanochemia Pharmazeutika
  • Developer Neurana Pharmaceuticals; Sanochemia Pharmazeutika
  • Class Analgesics; Antispasmodics; Antispastics; Muscle relaxants; Propiophenones; Pyridines; Small molecules
  • Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Muscle hypertonia; Muscle spasticity
  • Phase III Back pain
  • No development reported Spasm

Most Recent Events

  • 28 Dec 2022 Tolperisone is still in phase III trials for Back pain in USA
  • 21 Mar 2022 Neurana Pharmaceuticals completes the phase III RESUME-1 trial in Back pain in USA (PO) (NCT04671082)
  • 29 Nov 2021 Neurana Pharmaceuticals completes enrolment in the RESUME-1 phase III trial for Back pain in US

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top